BOOST Pharma

BOOST Pharma ApS is a Danish company founded based on research from the Karolinska Institute, focusing on novel cell therapies for osteogenesis imperfecta (OI). The company's treatment approach holds a unique position in the market as it targets the underlying condition responsible for fractures and skeletal deformities, which sets it apart from any other products currently under development.